A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine Attacks in Children
Clinical trial NCT00210535 · COMPLETED
Trial details
- NCT number
- NCT00210535
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.